← Open Payments lookup

AMY LAMPARELLA: Open Payments

NPI 1093704652 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$440 in 18 payments from 9 companies in 2025. Trend: 2023 $787 · 2024 $812 · 2025 $440

Food & beverage: $440
CompanyPaymentsAmount
Astellas Pharma US Inc8$236
ABBVIE INC.2$43
Novo Nordisk Inc2$42
Abbott Laboratories1$25
Merck Sharp & Dohme LLC1$23
Philips North America LLC1$23
SANOFI PASTEUR INC.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
Exact Sciences Corporation1$14

Products named: Veozah, VRAYLAR, Ozempic, FREESTYLE LIBRE 3, CAPVAXIVE, Ambulatory Monitoring & Diagnostics Undivided, FLUZONE HIGH-DOSE, CAPLYTA.

Industry payments across MD — which companies pay providers there.